These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2452035)

  • 1. Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms.
    McEwan JR; Benjamin N; Larkin S; Fuller RW; Dollery CT; MacIntyre I
    Circulation; 1988 May; 77(5):1072-80. PubMed ID: 2452035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels.
    Cockcroft JR; Noon JP; Gardner-Medwin J; Bennett T
    Br J Clin Pharmacol; 1997 Jul; 44(1):57-60. PubMed ID: 9241097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
    Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
    Vanmolkot FH; Van der Schueren BJ; de Hoon JN
    Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of calcitonin gene related peptide (CGRP) and substance P (SP) in human skin.
    Schlereth T; Schukraft J; Krämer-Best HH; Geber C; Ackermann T; Birklein F
    Neuropeptides; 2016 Oct; 59():57-62. PubMed ID: 27344069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds.
    Withrington PG
    Br J Pharmacol; 1992 Oct; 107(2):296-302. PubMed ID: 1384909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilating actions of calcitonin gene-related peptide in normal man: comparison with atrial natriuretic peptide.
    Ando K; Ito Y; Ogata E; Fujita T
    Am Heart J; 1992 Jan; 123(1):111-6. PubMed ID: 1530893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig.
    Franco-Cereceda A; Rudehill A; Lundberg JM
    Eur J Pharmacol; 1987 Oct; 142(2):235-43. PubMed ID: 2446887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.
    Newby DE; Sciberras DG; Mendel CM; Gertz BJ; Boon NA; Webb DJ
    Br J Clin Pharmacol; 1997 May; 43(5):493-9. PubMed ID: 9159564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin-induced vasodilatation of human coronary arteries in vitro is mediated by calcitonin gene-related peptide rather than substance P or neurokinin A.
    Franco-Cereceda A; Rudehill A
    Acta Physiol Scand; 1989 Aug; 136(4):575-80. PubMed ID: 2476911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK1 and CGRP receptor-mediated dilatation of the carotid arterial bed of the anaesthetized rabbit.
    Perren MJ; Connor HE; Beattie DT
    Neuropeptides; 1996 Apr; 30(2):141-8. PubMed ID: 8771556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human subjects.
    Zelis R; Mansour EJ; Capone RJ; Mason DT
    J Clin Invest; 1974 Dec; 54(6):1247-58. PubMed ID: 4612057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P and calcitonin gene-related peptide in the chicken skin: distribution and cardiovascular effects.
    Sann H; Friedrich R; Pierau FK
    Neuropeptides; 1996 Jun; 30(3):273-81. PubMed ID: 8819151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sensory neuropeptides on canine bronchial and pulmonary vessels in vitro.
    McCormack DG; Salonen RO; Barnes PJ
    Life Sci; 1989; 45(25):2405-12. PubMed ID: 2481796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of substance P and calcitonin gene-related peptide on the pulmonary circulation.
    Adnot S; Cigarini I; Herigault R; Harf A
    J Appl Physiol (1985); 1991 Apr; 70(4):1707-12. PubMed ID: 1711523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint.
    Lam FY; Ferrell WR
    Br J Pharmacol; 1993 Mar; 108(3):694-9. PubMed ID: 7682133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses.
    Wallengren J; Håkanson R
    Eur J Pharmacol; 1987 Nov; 143(2):267-73. PubMed ID: 2446892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans.
    de Hoon JN; Pickkers P; Smits P; Struijker-Boudier HA; Van Bortel LM
    Clin Pharmacol Ther; 2003 Apr; 73(4):312-21. PubMed ID: 12709721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vasorelaxant effect of adrenomedullin, proadrenomedullin N-terminal 20 peptide and amylin in human skin.
    Hasbak P; Eskesen K; Lind H; Holst J; Edvinsson L
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):162-7. PubMed ID: 16918718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.